Bhupinderjit Ballagan
Physician Assistant · Belton, MONPI 1215568589
Payments from drug & device makers
Across 108 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$243
- Daiichi Sankyo Inc.$217
- Sobi, Inc$173
- Incyte Corporation$123
- Lilly USA, LLC$120
- Bristol Myers Squibb$107
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,13097%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 13 | $243 |
| Daiichi Sankyo Inc. | 6 | $217 |
| Sobi, Inc | 5 | $173 |
| Incyte Corporation | 7 | $123 |
| Lilly USA, LLC | 7 | $120 |
| Bristol Myers Squibb | 7 | $107 |
| Bayer | 5 | $105 |
| Johnson & Johnson | 4 | $104 |
| Eisai Inc. | 5 | $82 |
| Pfizer | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| AbbVie | 3 | $62 |
| Novartis | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| Genentech USA, Inc. | 2 | $43 |
| GSK | 2 | $41 |
| Sanofi | 2 | $40 |
| Mylan Institutional Inc. | 2 | $37 |
| Amgen | 2 | $36 |
| Karyopharm Therapeutics Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Gilead | 2 | $32 |
| Stemline Therapeutics Inc. | 2 | $32 |
| AstraZeneca | 2 | $31 |
| Octapharma USA, Inc. | 1 | $25 |
| Array Biopharma Inc | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| AVEO Pharmaceuticals, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $18 |
| G1 Therapeutics, Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Pharmaand GmbH | 1 | $15 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
| Servier Pharmaceuticals LLC | 1 | $14 |
| Grifols USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$110
How this compares
$2,205 in reported general payments places this provider in the 85th percentile of 1,380 physician assistant providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 17 | $684 |
| Prochlorperazine Maleate | 28 | $571 |
| Ondansetron Hcl | 11 | $61 |
| Prednisone | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Belton
- Jennifer DavissonKansas City$343K
- Andrew BergLees Summit$245K
- Sileen DowisKansas City$117K
- Daniel BeckSikeston$114K
- Amee RozancO Fallon$101K
- Autumn WillsCape Girardeau$37K
- Kimberly BrownSaint Louis$28K
- Marc ReitznerSpringfield$24K
- Justin AllphinOzark$23K
- Jacqueline CastagnoWentzville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.